Mechanical ventilation-associated lung fibrosis in acute respiratory distress syndrome: a significant contributor to poor outcome
- PMID: 24732023
- PMCID: PMC4991945
- DOI: 10.1097/ALN.0000000000000264
Mechanical ventilation-associated lung fibrosis in acute respiratory distress syndrome: a significant contributor to poor outcome
Abstract
One of the most challenging problems in critical care medicine is the management of patients with the acute respiratory distress syndrome. Increasing evidence from experimental and clinical studies suggests that mechanical ventilation, which is necessary for life support in patients with acute respiratory distress syndrome, can cause lung fibrosis, which may significantly contribute to morbidity and mortality. The role of mechanical stress as an inciting factor for lung fibrosis versus its role in lung homeostasis and the restoration of normal pulmonary parenchymal architecture is poorly understood. In this review, the authors explore recent advances in the field of pulmonary fibrosis in the context of acute respiratory distress syndrome, concentrating on its relevance to the practice of mechanical ventilation, as commonly applied by anesthetists and intensivists. The authors focus the discussion on the thesis that mechanical ventilation-or more specifically, that ventilator-induced lung injury-may be a major contributor to lung fibrosis. The authors critically appraise possible mechanisms underlying the mechanical stress-induced lung fibrosis and highlight potential therapeutic strategies to mitigate this fibrosis.
Conflict of interest statement
Dr. Slutsky consults for Gambro Inc. (Grobenzell, Germany), Maquet Medical (Solna, Sweden), Novalung GmbH (Heilbronn, Germany), GSK (Mississauga, Ontario, Canada), and Apeiron Biologics AG (Vienna, Austria). The other authors declare no competing interests.
Figures





Similar articles
-
What the concept of VILI has taught us about ARDS management.Intensive Care Med. 2016 May;42(5):811-813. doi: 10.1007/s00134-016-4287-6. Epub 2016 Mar 3. Intensive Care Med. 2016. PMID: 26940945 No abstract available.
-
The physical basis of ventilator-induced lung injury.Expert Rev Respir Med. 2010 Jun;4(3):373-85. doi: 10.1586/ers.10.28. Expert Rev Respir Med. 2010. PMID: 20524920 Free PMC article. Review.
-
Effects of mechanical ventilation on the interstitial extracellular matrix in healthy lungs and lungs affected by acute respiratory distress syndrome: a narrative review.Crit Care. 2024 May 15;28(1):165. doi: 10.1186/s13054-024-04942-y. Crit Care. 2024. PMID: 38750543 Free PMC article. Review.
-
Near-Apneic Ventilation Decreases Lung Injury and Fibroproliferation in an Acute Respiratory Distress Syndrome Model with Extracorporeal Membrane Oxygenation.Am J Respir Crit Care Med. 2019 Mar 1;199(5):603-612. doi: 10.1164/rccm.201805-0869OC. Am J Respir Crit Care Med. 2019. PMID: 30216736
-
Lung and Diaphragm Protection During Mechanical Ventilation in Patients with Acute Respiratory Distress Syndrome.Clin Chest Med. 2024 Dec;45(4):863-875. doi: 10.1016/j.ccm.2024.08.007. Epub 2024 Sep 20. Clin Chest Med. 2024. PMID: 39443003 Review.
Cited by
-
Antifibrotics in COVID-19 Lung Disease: Let Us Stay Focused.Front Med (Lausanne). 2020 Sep 9;7:539. doi: 10.3389/fmed.2020.00539. eCollection 2020. Front Med (Lausanne). 2020. PMID: 33072773 Free PMC article.
-
Advances in the use of exosomes for the treatment of ALI/ARDS.Front Immunol. 2022 Aug 9;13:971189. doi: 10.3389/fimmu.2022.971189. eCollection 2022. Front Immunol. 2022. PMID: 36016948 Free PMC article. Review.
-
Post-COVID-19 Pulmonary Fibrosis: Novel Sequelae of the Current Pandemic.J Clin Med. 2021 Jun 1;10(11):2452. doi: 10.3390/jcm10112452. J Clin Med. 2021. PMID: 34205928 Free PMC article. Review.
-
Six-Month Pulmonary Impairment after Severe COVID-19: A Prospective, Multicentre Follow-Up Study.Respiration. 2021;100(11):1078-1087. doi: 10.1159/000518141. Epub 2021 Aug 19. Respiration. 2021. PMID: 34515212 Free PMC article.
-
Predictive monitoring and therapeutic immune biomarkers in the management of clinical complications of COVID-19.Cytokine Growth Factor Rev. 2021 Apr;58:32-48. doi: 10.1016/j.cytogfr.2020.10.002. Epub 2020 Oct 9. Cytokine Growth Factor Rev. 2021. PMID: 33199179 Free PMC article. Review.
References
-
- Villar J. Ventilator or physician-induced lung injury? Minerva Anestesiol. 2005;71:255–8. - PubMed
-
- Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS. Acute respiratory distress syndrome: The Berlin definition. JAMA. 2012;307:2526–33. - PubMed
-
- Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, Hudson LD. Incidence and outcomes of acute lung injury. N Engl J Med. 2005;353:1685–93. - PubMed
-
- Piantadosi CA, Schwartz DA. The acute respiratory distress syndrome. Ann Intern Med. 2004;141:460–70. - PubMed
-
- Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149(3 Pt 1):818–24. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical